The Case Files: Polyarthralgias, Rash, Swelling of Joints

By Alice Chao, MD, and Ayesha Khan, MD, MPH
 
A 44-year-old previously healthy woman presented to the emergency department with chest pain and shortness of breath. The patient reported a two-month history of polyarthralgias and rash. She initially noted swelling and pain of her ankles that progressed to her knees, wrists, and shoulders.
 
The patient also reported a non-pruritic rash with erythematous borders on her extremities that would come and go (Figure 1), nodules in her skin, and intermittent fevers.
 
Figure 1.
 
She denied any insect bites or recent travel, and had no personal or family history of autoimmune disorders. She reported a sore throat two weeks prior to onset of symptoms that was not treated. The patient was found to be in sinus tachycardia (Figure 2), and she complained of chest pressure and difficulty breathing.
 
Figure 2.
 
She continued to have persistent tachycardia despite fluid hydration and pain control. A CT angiogram of the chest was negative for pulmonary embolism. The patient was admitted for persistent tachycardia and further workup of recent symptoms that were concerning for acute rheumatic fever. Laboratory tests revealed a high antistreptolysin O titer. Throat culture was positive for Streptococcus pyogenes.
 
She also had elevated ESR and CRP. An echocardiogram was done during the hospitalization, which revealed mild thickening of the mitral valve and aortic valve with mild mitral and aortic regurgitation. Echo also revealed minimal pericardial effusion. The treating physicians felt the patient met the criteria for acute rheumatic fever (major criteria: polyarthritis, carditis/valvulitis, erythema marginatum [Figure 3], subcutaneous nodules; minor criteria: fever, arthralgia, elevated ESR and CRP, prolonged PR interval).
 
Figure 3.
 
The patient was started on penicillin 250 mg four times a day for two weeks, followed by 250 mg BID indefinitely for prophylaxis. She was also discharged on prednisone 40 mg daily and ibuprofen 800 mg TID for symptomatic relief. The patient's arthralgias and rash improved after treatment was initiated, and she is being followed by rheumatology and cardiology as an outpatient. Acute rheumatic fever (ARF) is a delayed sequela of group A streptococcus (GAS) pharyngeal infection.
 
A latent period of two to three weeks precedes the first signs of ARF. ARF and subsequent rheumatic heart disease affect almost 20 million people in the developing world, and are the leading cause of cardiovascular death in patients under age 50. (Lancet Infect Dis 2005;5[11]:685.) The mean incidence is 19 per 100,000 population.
 
A much lower incidence of ARF is reported in the United States and developed countries, likely because of improved hygienic standard and routine antibiotic treatment of acute pharyngitis. The incidence of ARF in developed countries has been as low as two to 14 cases per 100,000, though recent local outbreaks have occurred. (Circulation 2009;119[11]:1541; New Engl J Med 1987;316[8]:421; Pediatr Infect Dis J 1990;9[2]:97.)
 
T. Duckett Jones, MD, first described and published diagnostic criteria for acute rheumatic fever in 1944. (JAMA 1944;126[8]:481.) The American Heart Association subsequently established guidelines for diagnosing rheumatic fever (See Table 1 at end of article). (JAMA 1992; 268[15]:2069.)
 
A diagnosis of acute rheumatic fever requires the presence of two major manifestations or of one major and two minor manifestations with supporting evidence of a preceding group A streptococcal infection, according to the Jones criteria. Our patient had four major criteria (polyarthritis, carditis, erythema marginatum, and subcutaneous nodules) and four minor criteria (fever, arthralgia, elevated ESR and CRP, and prolonged PR interval). She also had elevated antistreptolysin O titers and a positive throat culture for group A streptococcus, both supporting a prior GAS infection.
 
The three major treatment goals of acute rheumatic fever are relief of symptoms, eradication of GAS, and prophylaxis against future GAS infection to prevent recurrent cardiac disease. Aspirin or other antiinflammtory agents are the mainstay of symptomatic management because of ARF, including relief of discomfort related to arthritis and fever.
 
Oral penicillin V is the drug of choice for eradication of GAS pharyngitis. Amoxicillin and cephalexin are also acceptable treatments. Approved alternatives for patients with potential severe hypersensitivity to beta-lactam antibiotics are azithromycin, clarithromycin, and clindamycin. (Circulation 2009;119[11]:1541.)
 
Prevention of recurrent GAS pharyngitis is the most effective method to limit progression of rheumatic heart disease because patients who have had rheumatic fever are at high risk for a recurrent attack. This secondary prevention requires continuous antibiotic prophylaxis, the duration of which depends on the risk of recurrence. Patients who have had rheumatic carditis are at relatively high risk for recurrence with cardiac involvement progressing with each recurrence.
 
Prophylaxis in these patients should continue until the patient reaches age 21 or for a total of 10 years (whichever is longer). Our 44-year-old patient, who is older than the typically affected population (ages 5–15), will need prophylaxis for several years. The antibiotic of choice for prophylaxis is IM penicillin G every four weeks or PO penicillin V twice daily. (Circulation 2009;119[11]:1541.)
 
Recent resurgence of rheumatic fever in the United States after years of decline suggests increases in undiagnosed and untreated cases of streptococcus pharyngitis. Rheumatic heart disease, a preventable illness, can lead to devastating complications such as cardiomyopathy, congestive heart failure, or complete heart block. It is important for physicians to remain diligent in diagnosing and treating cases of confirmed or suspected streptococcal pharyngitis.
 
Dr. Chao is a second-year resident in the Stanford/Kaiser
Emergency Medicine Residency Program. Dr. Khan is
a clinical instructor in emergency medicine at Stanford
University.
 
Table 1. Guidelines for Diagnosing an Initial Attack of Rheumatic Fever
 
Major Manifestations
Carditis
Polyarthritis
Chorea
Erythema marginatum
Subcutaneous nodules
 
Minor Manifestations
Clinical Findings

 Arthralgia
 Fever
Laboratory Findings
 Elevated acute phase reactants (ESR, CRP)
 Prolonged PR interval
Supporting Evidence of Antecedent Group A Streptococcal Infection
 Positive throat culture of rapid streptococcal antigen test
 Elevated or rising streptococcal antibody titer
 
Tags: Polyarthralgias, Rash, Swelling of Joints, rheumatic fever
Published: 4/29/2013 9:52:00 AM

The Case Files: Methanol or Ethanol Poisoning? Correct Diagnosis Influences Treatment

Sanaei-Zadeh, Hossein MD A 23-year-old man presented with agitation and decreased level of consciousness four hours after consuming homemade alcohol. He was brought in by a friend who had also ingested the same alcohol and was completely symptom-free. The patient had a history of seizures controlled by sodium valproate and a ventricular septal defect repaired in childhood. He was irritable, lethargic (Glasgow coma score: 12), and hypothermic. His pulse rate was 80 bpm, his respiratory rate was 20 bpm, and his blood pressure was 70/40 mm Hg. His pupils were midsized and reactive. Radial pulse was not detected, and carotid pulse was detected with difficulty. Bedside glucometery was determined to be 180 mg/dL. The patient's electrocardiogram is shown.The patient experienced cardiopulmonary arrest about 10 minutes after hospital presentation. Advanced life support was performed as were passive external and internal rewarming. The parameters of venous blood gas analysis were pH=7.15, HCO3=14.7, pCO2=43.2, and BE=-11.3. The lab test results were white blood cells, 11.1 × 103 /mm3; hemoglobin, 15.4; platelets, 187000/mm3; CPK, 49; CPK-MB, 29; blood urea nitrogen, 16; creatinine, 1.6; AST, 21 U/L; ALT,22 U/L; Na, 156 meq/L; and K,5.3 meq/L. He developed pulseless ventricular tachycardia without response to external pacing. Serum ethanol, methanol, formate, and lactate concentrations were not available. Ethanol was administered during the resuscitation via the nasogastric tube because of suspected methanol toxicity. The patient developed asystole two hours and 20 minutes after presentation, and did not respond to resuscitation. Methanol intoxication may regularly be seen endemically or sometimes epidemically because alcohol may contain methanol in countries where alcohol consumption is prohibited or the price of the commercially available alcohol is high. (J Med Toxicol 2011;7[3]:189; J Intern Med 2005;258[2]:181.) A severely ethanol-intoxicated patient usually presents with coma, hypotension, hypothermia, hypoventilation, respiratory arrest, mild acidosis associated with hypoglycemia, and an odor of ethanol on the breath. (Goldfrank's Toxicologic Emergencies, 9th Ed., New York: McGraw-Hill, 2011.) Severely methanol-intoxicated patients in contrast often present with coma, hypotension, tachycardia, tachypnea (to compensate for severe metabolic acidosis), seizure, and elevated blood glucose. (J Med Toxicol 2011;7[3]:189; J Intern Med 2005;258[2]:181; Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. 4th Ed., Philadelphia: Saunders Elsevier, 2007; J Med Toxicol 2011;7[3]:189.) The ethanol component of these alcohols postpones the metabolism of methanol, and these patients often present six to 24 hours post-ingestion with no odor of ethanol on the breath. (J Med Toxicol 2011;7[3]:189.) The patient's friend had consumed the same alcohol without signs or symptoms of methanol intoxication. The best clinical diagnosis for this patient is ethanol but not methanol intoxication, although there was no confirmatory test. The patient's ECG findings show he certainly was suffering from hypothermia. (Goldfrank's Toxicologic Emergencies, 9th Ed., New York: McGraw-Hill, 2011.) Administration of ethanol worsened his intoxication and hypothermia. The postmortem examination found the ethanol levels of the vitrous humor and blood samples were 70 and 129 mg/dL, respectively, and no methanol was detected in the patient's toxicological samples.
Published: 4/24/2013 6:46:00 AM